Literature DB >> 188543

Interrelationships and functions of the pyruvate kinase isozymes and their variant forms: a review.

K H Ibsen.   

Abstract

The relationships among and the properties of the pyruvate kinase isozymes are reviewed, emphasizing their potential role in carcinogenesis. Particular consideration is given to evaluation of the concept that the three major nonreadily interconvertible forms are the products of distinct genes, the relationship of these forms to additional separable forms of pyruvate kinase, the types and possible functions of interconvertible forms of the major isozymes, and mechanisms affecting the genetic expression of the isozymes. Emphasis is placed upon the apparent derepression of the fetal isozyme in hepatomas and the influence of neoplasms and their extracts on the expression of pyruvate kinase in the liver of host animals.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 188543

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Modulation of the liver specific phenotype in the human hepatoblastoma line Hep G2.

Authors:  J H Kelly; G J Darlington
Journal:  In Vitro Cell Dev Biol       Date:  1989-02

2.  Pyruvate kinase inhibited by L-cysteine as a marker of tumorigenic human urothelial cell lines.

Authors:  M Gumińska; M B Stachurska; B Christensen; V Tromholt; J Kieler; C Radzikowski; D Duś
Journal:  Experientia       Date:  1989-06-15

3.  High pyruvate kinase activity causes low concentration of 2,3-diphosphoglycerate in fetal rabbit red cells.

Authors:  W Jelkmann; C Bauer
Journal:  Pflugers Arch       Date:  1978-07-18       Impact factor: 3.657

4.  Purification and kinetic properties of pyruvate kinase isoenzymes of Salmonella typhimurium.

Authors:  C Garcia-Olalla; A Garrido-Pertierra
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

Review 5.  PKM2, cancer metabolism, and the road ahead.

Authors:  Talya L Dayton; Tyler Jacks; Matthew G Vander Heiden
Journal:  EMBO Rep       Date:  2016-11-17       Impact factor: 8.807

6.  Postnatal changes in canine erythrocyte pyruvate kinase isozymes.

Authors:  P A Mueggler; S Carpenter; J A Black
Journal:  Biochem Genet       Date:  1983-08       Impact factor: 1.890

7.  Pyruvate kinase and the "high ATP syndrome".

Authors:  G E Staal; G Jansen; D Roos
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

8.  Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Bertil Glader; Hitoshi Kanno; Archana Agarwal; Wilma Barcellini; Stefan Eber; James D Hoyer; David J Kuter; Tabita Magalhães Maia; Maria Del Mar Mañu-Pereira; Theodosia A Kalfa; Serge Pissard; José-Carlos Segovia; Eduard van Beers; Patrick G Gallagher; David C Rees; Richard van Wijk
Journal:  Am J Hematol       Date:  2018-11-28       Impact factor: 10.047

Review 9.  A critical review of the role of M2PYK in the Warburg effect.

Authors:  Robert A Harris; Aron W Fenton
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-01-29       Impact factor: 10.680

10.  Pancreatic islets contain the M2 isoenzyme of pyruvate kinase. Its phosphorylation has no effect on enzyme activity.

Authors:  M J MacDonald; C M Chang
Journal:  Mol Cell Biochem       Date:  1985-10       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.